| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/09/2003 | EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409765A Prevention of myocarditis, abortion and intrauterine infection associated with procine circovirus 2 |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409713A Fused heterotricyclic compound, process for preparing compounds and drugs containing the same |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409701A Crystalline form of (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyloxy phenyl} ethoxy) phenyl] propanoic acid |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1408854A Preparation and application of recombined human betaine homocysteine methyl transferase |
| 04/09/2003 | CN1408726A Preparation of non-mitogenic recombination acid fibrolast growth factor (aFGF) mutant |
| 04/09/2003 | CN1408438A Gene vaccine based on macrophage colony stimulating factor recepter and its use |
| 04/09/2003 | CN1408414A External use medicine for curing piles |
| 04/09/2003 | CN1408412A Specific medicine for curing pile, anal fissure and anal fistula |
| 04/09/2003 | CN1408411A Bear gall Korean ginseng pill for regulating blood pressure and its preparing method |
| 04/09/2003 | CN1408401A Cherry extract and its extracting method |
| 04/09/2003 | CN1408389A Traditional Chinese medicine for curing arrhythmia and its preparation |
| 04/09/2003 | CN1408366A Internal hemorrhoid injection |
| 04/09/2003 | CN1105116C Thienopyrimidine with PDE V-inhibiting effect |
| 04/09/2003 | CN1105115C 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]- spiro [isobenzofuran-1(3H),4'-piperidine)] hydrohalogenides |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105112C Benzothiophenecarboxamide derivatives and PGD2 antagonist comprising them |
| 04/09/2003 | CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor |
| 04/09/2003 | CN1104894C Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545055 Amidino-phenyl or -naphthyl aromatic amide derivatives |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545050 Aryl sulphonamide amino acid esters and analogues |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6545036 Potassium channel blockers; neuroprotectants, glaucoma, n-benzoyl indole compounds with 3-acylureamethyl group |
| 04/08/2003 | US6545031 Carboxyalkenylpyrazolylbenzene derivatives, such as (E)-alpha-((5-(2-((2-carboxyphenyl)methoxy)-4-methoxyphenyl) -1-ethyl-1H-pyrazol-4-yl)methylene)-6-methoxy-1,3-benzodioxole -5-propanoic acid |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/08/2003 | US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity. |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6545002 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy |
| 04/08/2003 | US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 04/08/2003 | US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein |
| 04/08/2003 | US6544992 Carbonylamino pyrrolidine and piperidine derivatives |
| 04/08/2003 | US6544991 Compositions and methods for treating bacterial infections |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544960 Chemical compounds |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544566 For prophylaxis and minimizing development of atherosclerosis |
| 04/08/2003 | US6544563 Synergistic mixture of arginine and nitric oxide synthase |
| 04/08/2003 | US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 04/08/2003 | US6544541 Devices and compounds for treating arterial restenosis |
| 04/08/2003 | US6544518 Vaccines |
| 04/08/2003 | US6544193 Noninvasive measurement of chemical substances |
| 04/08/2003 | CA2254152C New metalloprotease inhibitors, their preparation process and the pharmaceutical compositions which use them |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2123548C Piperazine derivatives |
| 04/08/2003 | CA2097824C Functionalized vinyl azoles and their use |
| 04/08/2003 | CA2065849C Vitamin d analogues |
| 04/08/2003 | CA2061907C Treatment of ocular hypertension with a synergistic combination |
| 04/08/2003 | CA2049212C 6-substituted-tetrahydrobenz ¬cd| indoles |
| 04/07/2003 | WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 04/04/2003 | CA2406610A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 04/03/2003 | WO2003027292A2 Regulation of human fatty acid-coa ligase-like enzyme |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027282A1 Adamts-15, -16, -17, -18 and -19 |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027232A2 Method for producing biologically active products |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003027116A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 04/03/2003 | WO2003027115A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 04/03/2003 | WO2003027114A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
| 04/03/2003 | WO2003027113A1 1,6-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027112A1 1, 8-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027111A1 Chemical compounds |
| 04/03/2003 | WO2003027108A1 Heterocyclic derivatives and their use as hypoglycaemic and hypolipidemic agents |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027093A1 Chemical compounds |
| 04/03/2003 | WO2003027091A1 Pyrane derivatives as both ace- and nep- inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027077A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 04/03/2003 | WO2003027076A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003027069A1 Preparation and use of pyrrole derivatives for treating obesity |
| 04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | WO2003026718A1 Coated implantable medical device |
| 04/03/2003 | WO2003026674A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |